Literature DB >> 5900210

Changes in sphingosine and fatty acid components of the gangliosides in developing rat and human brain.

A Rosenberg, N Stern.   

Abstract

Rat brain increases in weight after birth in three stages: (I) rapidly for the first 2 weeks, (II) at a lower rate from 2 to 5 weeks, and (III) at a still lower rate from 5 weeks to 5 months. During the succeeding period, designated IV, it maintains constant weight up to 1 year of age. Brain ganglioside content increased linearly during I and II, more slowly during III, and diminished during IV. The appearance of measurable amounts of brain sphingomyelin and cerebroside succeeded that of ganglioside. Ceramide with C18-sphingosine and C18 fatty acid was found in a large proportion of all three sphingolipids upon their first appearance in measurable quantity. C18 fatty acid in cerebroside rapidly declined to a negligible level, while in gangliosides and sphingomyelin it declined slowly but remained the major fatty acid component. Cerebrosides and sphingomyelin contained C18-sphingosine almost exclusively at all stages of rat brain growth. Gangliosides contained C18-sphingosine almost exclusively at birth, but subsequently accumulated C20-sphingosine until they had nearly equal quantities of each base type. Changes in human brain gangliosides resemble those in rat. In Tay-Sachs disease, gangliosides have C18-sphingosine predominantly, and a high content of C18 fatty acid.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5900210

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  22 in total

1.  Ketone bodies serve as important precursors of brain lipids in the developing rat.

Authors:  Y Y Yeh; V L Streuli; P Zee
Journal:  Lipids       Date:  1977-11       Impact factor: 1.880

2.  Fatty acid and long chain base composition of adrenal medulla gangliosides.

Authors:  R Ledeen; K Salsman
Journal:  Lipids       Date:  1970-09       Impact factor: 1.880

3.  Fatty acid composition of free ceramides of kidney and cerebellum from a patient with Farber's disease.

Authors:  M Sugita; P Connolly; J T Dulaney; H W Moser
Journal:  Lipids       Date:  1973-07       Impact factor: 1.880

Review 4.  Sphingolipid long chain bases.

Authors:  K A Karlsson
Journal:  Lipids       Date:  1970-11       Impact factor: 1.880

5.  A comparative study of gangliosides from brains of various species.

Authors:  C L Schengrund; O W Garrigan
Journal:  Lipids       Date:  1969-11       Impact factor: 1.880

6.  Elevation of 20-carbon long chain bases due to a mutation in serine palmitoyltransferase small subunit b results in neurodegeneration.

Authors:  Lihong Zhao; Stefka Spassieva; Kenneth Gable; Sita D Gupta; Lan-Ying Shi; Jieping Wang; Jacek Bielawski; Wanda L Hicks; Mark P Krebs; Juergen Naggert; Yusuf A Hannun; Teresa M Dunn; Patsy M Nishina
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-05       Impact factor: 11.205

7.  Sphingolipid metabolism. II. The biosynthesis of 3-keto-dihydrosphingosine by a partially-purified enzyme from rat brain.

Authors:  J N Kanfer; S Bates
Journal:  Lipids       Date:  1970-08       Impact factor: 1.880

8.  Differences in the long chain (sphingoid) base composition of sphingomyelin from rats bearing Morris hepatoma 7777.

Authors:  A H Merrill; E Wang; P W Wertz
Journal:  Lipids       Date:  1986-08       Impact factor: 1.880

9.  Possible role of ceramide in defining structure and function of membrane glycolipids.

Authors:  R Kannagi; E Nudelman; S Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

10.  Liquid chromatography-high-resolution mass spectrometry for quantitative analysis of gangliosides.

Authors:  Bertram Fong; Carmen Norris; Edwin Lowe; Paul McJarrow
Journal:  Lipids       Date:  2009-07-26       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.